Hedge Fund - Darwin Global Management
Keros Therapeutics Inc. (KROS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $95,059,890 | 12.65% | 1,435,950 | $59.30 |
| 2 | 2023 - Q4 (2023-12-31) | $42,162,578 | 8.27% | 1,060,427 | $31.36 |
| 3 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $43.84 |
| 4 | 2023 - Q1 (2023-03-31) | $1,340,182 | 0.36% | 31,386 | $50.51 |
| 5 | 2022 - Q4 (2022-12-31) | $20,578,107 | 12.81% | 428,532 | $46.71 |
| 6 | 2022 - Q1 (2022-03-31) | $0 | 0% | 0 | $51.33 |
| 7 | 2021 - Q4 (2021-12-31) | $6,524,000 | 0.99% | 111,500 | $49.87 |
| 8 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $35.59 |
| 9 | 2021 - Q2 (2021-06-30) | $4,425,000 | 0.71% | 104,186 | $54.17 |
| 10 | 2021 - Q1 (2021-03-31) | $5,348,000 | 1.04% | 86,887 | $63.36 |
The displayed share prices are average quarterly stock market prices.